New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
07:17 EDTVRTXVertex shares should be bought on pullbacks, says RBC Capital
RBC Capital recommends buying Vertex on pullbacks as it thinks the stock could move towards $80+ on positive Phase III CF combo data in 1H14. The firm maintains a $70 price target and Outperform rating on the shares.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
13:42 EDTVRTXVertex peak CF sales have bullish read from Royalty Pharma bet, TheStreet says
Subscribe for More Information
10:42 EDTVRTXUBS hosts a conference call with Vertex Pharmaceuticals
Subscribe for More Information
07:52 EDTVRTXInforma Business Information to hold a conference
Subscribe for More Information
07:27 EDTVRTXRoyalty Pharma acquires royalties on Vertex Pharmaceuticals CF treatments
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use